Teenage Opioid Use Doubles in Ottawa
A report from Ottawa Public Health shows a shocking increase in teenage opioid use, doubling in just two years.
Controlled-Release Medication Could Improve Outcomes in Addiction Treatment
Researchers at VCU have formulated a drug that works better than methadone or buprenorphine at treating opioid use disorder.
The Profit Potential in the Opioid Epidemic
A journal for pharmaceutical investors takes a look at the profit potential in treating opioid use disorders.
Preventing Relapse During Recovery From Opioid Use Disorder
Researchers at the University of Maryland team up to study the genetics of relapse during recovery from opioid use disorder.
The Under Use of Buprenorphine for Opioid Use Disorder
The New York Times Magazine takes a long look at the history of the opioid crisis and the under use of buprenorphine for opioid use disorder.
Will Journavx, a New, Non-Addictive Painkiller, Eliminate Opioid Addiction?
The FDA has approved suzetrigine, a non-opiate signal blocker, for treatment of moderate and severe acute pain.